203 related articles for article (PubMed ID: 8745930)
1. Vaccines against leishmaniasis.
Modabber F
Ann Trop Med Parasitol; 1995 Dec; 89 Suppl 1():83-8. PubMed ID: 8745930
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in vaccines for leishmaniasis.
Requena JM; Iborra S; Carrión J; Alonso C; Soto M
Expert Opin Biol Ther; 2004 Sep; 4(9):1505-17. PubMed ID: 15335317
[TBL] [Abstract][Full Text] [Related]
3. [Approaches and problems in vaccine development against leishmaniasis].
Allahverdiyev A; Bağirova M; Cakir Koç R; Oztel ON; Elçıçek S; Ateş SC; Karaca TD
Turkiye Parazitol Derg; 2010; 34(2):122-30. PubMed ID: 20597059
[TBL] [Abstract][Full Text] [Related]
4. Progress on vaccines against parasites.
Engers HD; Bergquist R; Modabber F
Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004
[TBL] [Abstract][Full Text] [Related]
5. Vaccines for leishmaniasis in the fore coming 25 years.
Palatnik-de-Sousa CB
Vaccine; 2008 Mar; 26(14):1709-24. PubMed ID: 18295939
[TBL] [Abstract][Full Text] [Related]
6. Progress towards a Leishmania vaccine.
Tabbara KS
Saudi Med J; 2006 Jul; 27(7):942-50. PubMed ID: 16830009
[TBL] [Abstract][Full Text] [Related]
7. Vaccines for visceral leishmaniasis: A review.
Jain K; Jain NK
J Immunol Methods; 2015 Jul; 422():1-12. PubMed ID: 25858230
[TBL] [Abstract][Full Text] [Related]
8. Possibilities and challenges for developing a successful vaccine for leishmaniasis.
Srivastava S; Shankar P; Mishra J; Singh S
Parasit Vectors; 2016 May; 9(1):277. PubMed ID: 27175732
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified live attenuated parasites as vaccines for leishmaniasis.
Selvapandiyan A; Duncan R; Debrabant A; Lee N; Sreenivas G; Salotra P; Nakhasi HL
Indian J Med Res; 2006 Mar; 123(3):455-66. PubMed ID: 16778323
[TBL] [Abstract][Full Text] [Related]
10. Second-generation vaccines against leishmaniasis.
Coler RN; Reed SG
Trends Parasitol; 2005 May; 21(5):244-9. PubMed ID: 15837614
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis.
Noazin S; Khamesipour A; Moulton LH; Tanner M; Nasseri K; Modabber F; Sharifi I; Khalil EA; Bernal ID; Antunes CM; Smith PG
Vaccine; 2009 Jul; 27(35):4747-53. PubMed ID: 19540273
[TBL] [Abstract][Full Text] [Related]
12. Leishmaniasis: prevention, parasite detection and treatment.
Kobets T; Grekov I; Lipoldova M
Curr Med Chem; 2012; 19(10):1443-74. PubMed ID: 22360481
[TBL] [Abstract][Full Text] [Related]
13. Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis.
Okwor I; Liu D; Uzonna J
Vaccine; 2009 Apr; 27(19):2554-62. PubMed ID: 19428861
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated Leishmania vaccines: a potential strategic alternative.
Silvestre R; Cordeiro-da-Silva A; Ouaissi A
Arch Immunol Ther Exp (Warsz); 2008; 56(2):123-6. PubMed ID: 18373245
[TBL] [Abstract][Full Text] [Related]
15. Meetings on vaccine studies towards the control of leishmaniasis. UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) February 13-22 and April 4-5, 1995.
Grimaldi Júnior G
Mem Inst Oswaldo Cruz; 1995; 90(4):553-6. PubMed ID: 8551962
[No Abstract] [Full Text] [Related]
16. Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery.
Mendonça SC
Parasit Vectors; 2016 Sep; 9(1):492. PubMed ID: 27600664
[TBL] [Abstract][Full Text] [Related]
17. Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis.
Reis AB; Giunchetti RC; Carrillo E; Martins-Filho OA; Moreno J
Trends Parasitol; 2010 Jul; 26(7):341-9. PubMed ID: 20488751
[TBL] [Abstract][Full Text] [Related]
18. The immunology of Leishmania infection and the implications for vaccine development.
Vanloubbeeck Y; Jones DE
Ann N Y Acad Sci; 2004 Oct; 1026():267-72. PubMed ID: 15604504
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of an autoclaved Leishmania major vaccine.
Khalil EA; Elhassan AM; Zijlstra EE; Osman OF; Eljack IA; Ibrahim ME; Mukhtar MM; Ghalib HW; Modabbers F
East Afr Med J; 2000 Sep; 77(9):468-70. PubMed ID: 12862135
[TBL] [Abstract][Full Text] [Related]
20. Methods to Evaluate the Preclinical Safety and Immunogenicity of Genetically Modified Live-Attenuated Leishmania Parasite Vaccines.
Gannavaram S; Bhattacharya P; Dey R; Ismail N; Avishek K; Salotra P; Selvapandiyan A; Satoskar A; Nakhasi HL
Methods Mol Biol; 2016; 1403():623-38. PubMed ID: 27076157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
